Synthesis, anti-bacterial and anti-protozoal activities of amidinobenzimidazole derivatives and their interactions with DNA and RNA

References

• Akhtar W, Khan MF, Verma G, et al. Therapeutic evolution of benzimidazole derivatives in the last quinquennial period. Eur J Med Chem 2017;126:705–53.
   PubMed Web of Science ®Google Scholar
• Akhtar J, Khan AA, Ali Z, et al. Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities. Eur J Med Chem 2017;125:143–89.
   PubMed Web of Science ®Google Scholar
• Yadav G, Ganguly S. Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: a mini-review. Eur J Med Chem 2015;97:419–43.
   PubMed Web of Science ®Google Scholar
• Akhtar MJ, Siddiqui AA, Khan AA, et al. Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors. Eur J Med Chem 2017;126:853–69.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Chaudhuri P. Medical implications of benzimidazole derivatives as drugs designed for targeting DNA and DNA associated processes. Curr Med Chem 2008;15:1762–77.
   PubMed Web of Science ®Google Scholar
• Sontakke VA, Lawande PP, Kate AN, et al. Antiproliferative activity of bicyclic benzimidazole nucleosides: synthesis, DNA-binding and cell cycle analysis. Org Biomol Chem 2016;14:4136–45.
   PubMed Web of Science ®Google Scholar
• Hegde M, Kumar KSS, Thomas E, et al. A novel benzimidazole derivative binds to the DNA minor groove and induces apoptosis in leukemic cells. RSC Adv 2015;5:93194–208.
   Web of Science ®Google Scholar
• Singla P, Luxami V, Paul K. Triazine–benzimidazole conjugates: synthesis, spectroscopic and molecular modelling studies for interaction with calf thymus DNA. RSC Adv 2016;6:14741–50.
   Web of Science ®Google Scholar
• Chaudhuri P, Ganguly B, Bhattacharya S. An experimental and computational analysis on the differential role of the positional isomers of symmetric bis-2-(pyridyl)-1H-benzimidazoles as DNA binding agents. J Org Chem 2007;72:1912–23.
   PubMed Web of Science ®Google Scholar
• Thomas JR, Hergenrother PJ. Targeting RNA with small molecules. Chem Rev 2008;108:1171–224.
   PubMed Web of Science ®Google Scholar
• Guan L, Disney MD. Recent advances in developing small molecules targeting RNA. ACS Chem Biol 2012;7:73–86.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Cai X, Bradley JE. MicroRNAs in parasites and parasite infection. RNA Biol 2013;10:371–9.
   PubMed Web of Science ®Google Scholar
• Cheng G, Dai M, Ahmed S, et al. Antimicrobial drugs in fighting against antimicrobial resistance. Front Microbiol 2016;7:470.
   PubMed Web of Science ®Google Scholar
• Cassir N, Rolain JM, Brouqui P. A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol 2014;5:551.
   PubMed Web of Science ®Google Scholar
• Yang SW, Pan J, Yang C, et al. Benzimidazole analogs as WTA biosynthesis inhibitors targeting methicillin resistant Staphylococcus aureus. Bioorg Med Chem Lett 2016;26:4743–7.
   PubMed Web of Science ®Google Scholar
• Hu L, Kully ML, Boykin DW, Abood N. Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents. Bioorg Med Chem Lett 2009;19:3374–7.
   PubMed Web of Science ®Google Scholar
• Rodrigo‐Troyano A, Sibila O. The respiratory threat posed by multidrug resistant Gram‐negative bacteria. Respirology 2017;22:1288–99.
   PubMed Web of Science ®Google Scholar
• Ansari KF, Lal C. Synthesis and evaluation of some new benzimidazole derivatives as potential antimicrobial agents. Eur J Med Chem 2009;44:2294–9.
   PubMed Web of Science ®Google Scholar
• Sharma D, Narasimhan B, Kumar P, Jalbout A. Synthesis and QSAR evaluation of 2-(substituted phenyl)-1H-benzimidazoles and [2-(substituted phenyl)-benzimidazol-1-yl]-pyridin-3-yl-methanones. Eur J Med Chem 2009;44:1119–27.
   PubMed Web of Science ®Google Scholar
• Ates-Alagoz Z. Antimicrobial activities of 1-H-benzimidazole-based molecules. Curr Top Med Chem 2016;16:2953–62.
   PubMed Web of Science ®Google Scholar
• Song D, Ma S. Recent development of benzimidazole‐containing antibacterial agents. Chem Med Chem 2016;11:646–59.
   Web of Science ®Google Scholar
• Desai N, Trivedi A, Pandit U, et al. Hybrid bioactive heterocycles as potential antimicrobial agents: a review. Mini Rev Med Chem 2016;16:1500–26.
   PubMed Web of Science ®Google Scholar
• El-Gohary NS, Shaaban MI. Synthesis and biological evaluation of a new series of benzimidazole derivatives as antimicrobial, antiquorum-sensing and antitumor agents. Eur J Med Chem 2017;131:255–62.
   PubMed Web of Science ®Google Scholar
• Klimesová V, Kocí J, Pour M, et al. Synthesis and preliminary evaluation of benzimidazole derivatives as antimicrobial agents. Eur J Med Chem 2002;37:409–18.
   PubMed Web of Science ®Google Scholar
• Gibney KA, Sovadinova I, Lopez AI, et al. Poly(ethylene imine)s as antimicrobial agents with selective activity. Macromol Biosci 2012;12:1279–89.
   PubMed Web of Science ®Google Scholar
• Sharma V, Chitranshi N, Agarwal AK. Significance and biological importance of pyrimidine in the microbial world. Int J Med Chem 2014;2014:202784.
   PubMedGoogle Scholar
• Anthony NG, Breen D, Clarke J, et al. Antimicrobial lexitropsins containing amide, amidine, and alkene linking groups. J Med Chem 2007;50:6116–25.
   PubMed Web of Science ®Google Scholar
• Bonandi E, Christodoulou MS, Fumagalli G, et al. The 1,2,3-triazole ring as a bioisostere in medicinal chemistry. Drug Discov Today 2017;22:1572–81.
   PubMed Web of Science ®Google Scholar
• Dheer D, Singh V, Shankar R. Medicinal attributes of 1,2,3-triazoles: current developments. Bioorg Chem 2017;71:30–54.
   PubMed Web of Science ®Google Scholar
• Tiwari VK, Mishra BB, Mishra KB, et al. Cu-catalyzed click reaction in carbohydrate chemistry. Chem Rev 2016;116:3086–240.
   PubMed Web of Science ®Google Scholar
• DeSimone RW, Currie KS, Mitchell SA, et al. Privileged structures: applications in drug discovery. Comb Chem High Throughput Screening 2004;7:473–93.
   PubMed Web of Science ®Google Scholar
• Gaba M, Singh S, Mohan C. Benzimidazole: an emerging scaffold for analgesic and anti-inflammatory agents. Eur J Med Chem 2014;76:494–505.
   PubMed Web of Science ®Google Scholar
• Jadhav GR, Shaikh MU, Kale RP, et al. SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents. Eur J Med Chem 2009;44:2930–5.
   PubMed Web of Science ®Google Scholar
• Kühler TC, Swanson M, Christenson B, et al. Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 1. J Med Chem 2002;45:4282–99.
   PubMed Web of Science ®Google Scholar
• Maračić S, Kraljević TG, Paljetak HČ, et al. 1,2,3-Triazole pharmacophore-based benzofused nitrogen/sulfur heterocycles with potential anti-Moraxella catarrhalis activity. Bioorg Med Chem 2015;23:7448–63.
   PubMed Web of Science ®Google Scholar
• Ranjan N, Story S, Fulcrand G, et al. Selective inhibition of Escherichia coli RNA and DNA topoisomerase I by Hoechst 33258 derived mono- and bisbenzimidazoles. J Med Chem 2017;60:4904–22.
   PubMed Web of Science ®Google Scholar
• Grillot AL, Tiran AL, Shannon D, et al. Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liability. J Med Chem 2014;57:8792–816.
   PubMed Web of Science ®Google Scholar
• Janupally R, Jeankumar VU, Bobesh KA, et al. Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyrase B enzyme of Staphylococcus aureus. Bioorg Med Chem 2014;22:5970–87.
   PubMed Web of Science ®Google Scholar
• Lam T, Hilgers MT, Cunningham ML, et al. Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines. J Med Chem 2014;57:651–68.
   PubMed Web of Science ®Google Scholar
• Whalen KL, Chau AC, Spies MA. In silico Optimization of a Fragment‐Based Hit Yields Biologically Active, High‐Efficiency Inhibitors for Glutamate Racemase. ChemMedChem 2013;8:1681–1689.
   PubMed Web of Science ®Google Scholar
• Pan W, Fan M, Wu H, et al. A new small molecule inhibits Streptococcus mutans biofilms in vitro and in vivo. J Appl Microbiol 2015;119:1403–11.
   PubMed Web of Science ®Google Scholar
• Luo G, Spellberg B, Gebremariam T, et al. Combination therapy with iron chelation and vancomycin in treating murine staphylococcemia. Eur J Clin Microbiol Infect Dis 2014;33:845–51.
   PubMed Web of Science ®Google Scholar
• Nimesh H, Sur S, Sinha D, et al. Synthesis and biological evaluation of novel bisbenzimidazoles as Escherichia coli topoisomerase IA inhibitors and potential antibacterial agents. J Med Chem 2014;57:5238–57.
   PubMed Web of Science ®Google Scholar
• Mann J, Taylor PW, Dorgan CR, et al. The discovery of a novel antibiotic for the treatment of Clostridium difficile infections: a story of an effective academic–industrial partnership. MedChemComm 2015;6:1420–6.
   PubMed Web of Science ®Google Scholar
• Farahat AA, Bennett-Vaughn C, Mineva EM, et al. Synthesis, DNA binding and antitrypanosomal activity of benzimidazole analogues of DAPI. Bioorg Med Chem Lett 2016;26:5907–10.
   PubMed Web of Science ®Google Scholar
• Karaaslan C, Kaiser M, Brun R, Göker H. Synthesis and potent antiprotozoal activity of mono/di amidino 2-anilinobenzimidazoles versus Plasmodium falciparum and Trypanosoma brucei rhodesiense. Bioorg Med Chem 2016;24:4038–44.
   PubMed Web of Science ®Google Scholar
• Ismail MA, Batista-Parra A, Miao Y, et al. Dicationic near-linear biphenyl benzimidazole derivatives as DNA-targeted antiprotozoal agents. Bioorg Med Chem 2005;13:6718–26.
   PubMed Web of Science ®Google Scholar
• Rice CA, Colon BL, Alp M, et al. Bis-benzimidazole hits against Naegleria fowleri discovered with new high-throughput screens. Antimicrob Agents Chemother 2015;59:2037–44.
   PubMed Web of Science ®Google Scholar
• Alp M, Göker H, Brun R, Yildiz S. Synthesis and antiparasitic and antifungal evaluation of 2′-arylsubstituted-1H,1′H-[2,5']bisbenzimidazolyl-5-carboxamidines. Eur J Med Chem 2009;44:2002–8.
   PubMed Web of Science ®Google Scholar
• Sola I, Artigas A, Taylor MC, et al. Synthesis and biological evaluation of N-cyanoalkyl-, N-aminoalkyl-, and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agents. Bioorg Med Chem 2016;24:5162–71.
   PubMed Web of Science ®Google Scholar
• Pai S, Alam AS, Kapoor JN. Pentamidine salts useful in the treatment of pneumocystis carinii pneumonia, US. Patent Application US/07383, 243. US5084480 A, Fujisawa USA Inc., 1992.
   Google Scholar
• Jensch H4. 4'-Diamidino-diazoaminobenzene, a new agent in the treatment of trypanosomiasis and babesiasis. Arzneimitt Forsch 1955;5:634–635.
   PubMed Web of Science ®Google Scholar
• Ansede JH, Anbazhagan M, Brun R, et al. As indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense infection. J Med Chem 2004;47:4335–8.
   PubMed Web of Science ®Google Scholar
• Bakunov SA, Bakunova SM, Wenzler T, et al. Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1H-1,2,3-triazoles. J Med Chem 2010;53:254–72.
   PubMed Web of Science ®Google Scholar
• Bistrović A, Krstulović L, Harej A, et al. Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer. Eur J Med Chem 2018;143:1616–34. 2017
   PubMed Web of Science ®Google Scholar
• Stolić I, Paljetak HČ, Perić M, et al. Synthesis and structure–activity relationship of amidine derivatives of 3,4-ethylenedioxythiophene as novel antibacterial agents. Eur J Med Chem 2015;90:68–81.
   PubMed Web of Science ®Google Scholar
• Krstulović L, Stolić I, Jukić M, et al. New quinoline-arylamidine hybrids: synthesis, DNA/RNA binding and antitumor activity. Eur J Med Chem 2017;137:196–210.
   PubMed Web of Science ®Google Scholar
• Hranjec M, Starčević K, Zamola B, et al. New amidino-benzimidazolyl derivatives of tylosin and desmycosin. J Antibiot 2002;55:308–14.
   PubMed Web of Science ®Google Scholar
• Chandrika NT, Shrestha SK, Ngo HX, Garneau-Tsodikova S. Synthesis and investigation of novel benzimidazole derivatives as antifungal agents. Bioorg Med Chem 2016;24:3680–6.
   PubMed Web of Science ®Google Scholar
• Kumar R, Arora J, Prasad AK, et al. Synthesis and antimicrobial activity of pyrimidine chalcones. Med Chem Res 2013;22:5624–32.
   Web of Science ®Google Scholar
• Harbeck RJ, McCarter YS, Ortez JH, et al. Manual of antimicrobial susceptibility testing, Washington: American Society for Microbiology; 2005.
   Google Scholar
• Stolić I, Mišković K, Magdaleno A, et al. Effect of 3,4-ethylenedioxy-extension of thiophene core on the DNA/RNA binding properties and biological activity of bisbenzimidazole amidines. Bioorg Med Chem 2009;17:2544–54.
   PubMed Web of Science ®Google Scholar
• Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci 1949;51:660–72.
   Web of Science ®Google Scholar
• McGhee JD, von Hippel PH. Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. J Mol Biol 1974 1974;86:469–89.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A7, Wayne (PA): CLSI; 2006.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100-S17, Wayne (PA): CLSI; 2007.
   Google Scholar
• Taylor MC, Lewis MD, Fortes Francisco A, et al. The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulence. PLoS Negl Trop Dis 2015;9:e0003707.
   PubMed Web of Science ®Google Scholar
• Kappe CO, Van der Eycken E. Click chemistry under non-classical reaction conditions. Chem Soc Rev 2010;39:1280–90.
   PubMed Web of Science ®Google Scholar
• Ohemeng KA, Nguyen VN. Ortho -Mcneil Pharmaceutical. 2-substituted phenylbenzimidazole antibacterial agents, US. Patent Application 08/924,558, 1999, WO1999011627A1.
   Google Scholar
• Rehman SU, Sarwar T, Husain MA, et al. Studying non-covalent drug–DNA interactions. Arch Biochem Biophys 2015;576:49–60.
   PubMed Web of Science ®Google Scholar
• Arjmand F, Parveen S, Afzal M, et al. Molecular drug design, synthesis and crystal structure determination of Cu II–Sn IV heterobimetallic core: DNA binding and cleavage studies. Eur J Med Chem 2012;49:141–50.
   PubMed Web of Science ®Google Scholar
• Banerjee M, Farahat AA, Kumar A, et al. Synthesis, DNA binding and antileishmanial activity of low molecular weight bis-arylimidamides. Eur J Med Chem 2012;55:449–54.
   PubMed Web of Science ®Google Scholar
• Wilson WD, Tanious FA, Fernandez-Saiz M, Rigl CT. Evaluation of drug-nucleic acid interactions by thermal melting curves. Methods Mol Biol 1997;90:219–40.
   PubMedGoogle Scholar
• Mergny JL, Lacroix L. Analysis of thermal melting curves. Oligonucleotides 2003;13:515–37.
   PubMed Web of Science ®Google Scholar
• Husain MA, Yaseen Z, Rehman SU, et al. Naproxen intercalates with DNA and causes photocleavage through ROS generation. Febs J 2013;280:6569–80.
   PubMed Web of Science ®Google Scholar
• Rodger A. Circular dichroism and linear dichroism. Encyclopedia of Analytical Chemistry. John Hoboken (NJ): Wiley & Sons, Ltd. 2014.
   Google Scholar
• Liu Y, Kumar A, Boykin DW, Wilson WD. Sequence and length dependent thermodynamic differences in heterocyclic diamidine interactions at AT base pairs in the DNA minor groove. Biophys Chem 2007;131:1–14.
   PubMed Web of Science ®Google Scholar
• O'Sullivan P, Rozas I. Understanding the guanidine-like cationic moiety for optimal binding into the DNA minor groove . ChemMedChem 2014;9:2065–73.
   PubMed Web of Science ®Google Scholar
• Nagle PS, Quinn SJ, Kelly JM, et al. Understanding the DNA binding of novel non-symmetrical guanidinium/2-aminoimidazolinium derivatives. Org Biomol Chem 2010;8:5558–67.
   PubMed Web of Science ®Google Scholar
• Nguyen B, Tardy C, Bailly C, et al. Influence of compound structure on affinity, sequence selectivity, and mode of binding to DNA for unfused aromatic dications related to furamidine. Biopolymers 2002;63:281–97.
   PubMed Web of Science ®Google Scholar
• Dyatkina NB, Roberts CD, Keicher JD, et al. Minor groove DNA binders as antimicrobial agents. 1. Pyrrole tetraamides are potent antibacterials against vancomycin resistant Enteroccoci and methicillin resistant Staphylococcus aureus. J Med Chem 2002;45:805–17.
   PubMed Web of Science ®Google Scholar
• Khalaf AI. Minor groove binders: some recent research in drug development. Curr Trends Med Chem 2009;6:53–63.
   Google Scholar
• Havrylyuk D, Zimenkovsky B, Karpenko O, et al. Synthesis of pyrazoline–thiazolidinone hybrids with trypanocidal activity. Eur J Med Chem 2014;85:245–54.
   PubMed Web of Science ®Google Scholar